NEW YORK – Regulators are endeavoring to take steps to boost the prospects for small companies to partake in the initial public offering (IPO) market, but more can be done to help not only companies going public today, but those that went public in the pre-healthcare reform era and that have been burdened and are struggling with the side effects of overregulation for years, according to someone the SEC actually listens to.